Henry N. Ginsberg
2018–2018 OpenAlex profile ↗
Reproducibility track record
1
assessed papers
49/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
0
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
—
Funders
—
Frequent co-authors
Christian Schlein 1Jöerg Heeren 1Gabriella Belnavis 1Rajasekhar Ramakrishnan 1Samuel X. Lee 1Franz Rinninger 1Alexander W. Fischer 1Rebecca A. Haeusler 1Ido Haimi 1Markus Heine 1
Institutions
Columbia University 1Universität Hamburg 1University Medical Center Hamburg-Eppendorf 1
Geography (author institutions)
US 1DE 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (499)
Request a reproduction →1 assessed by us (0 reproduced) · 498 not yet assessed — every PubMed paper on record, linked below.
-
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte? ↗Pharmacology & Therapeutics · 2025 · PMID 39947256not yet assessed
-
Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know ↗Atherosclerosis · 2025 · PMID 41202476not yet assessed
-
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA ↗Atherosclerosis · 2025 · PMID 40068508not yet assessed
-
Breaking up prolonged sedentary behavior to improve cardiometabolic health (BREAK2): protocol for a dose-finding adaptive randomization trial ↗BMC Public Health · 2025 · PMID 40414835not yet assessed
-
In Memoriam: Scott M. Grundy (1933–2025) ↗Journal of Lipid Research · 2025 · PMID 40674931not yet assessed
-
ApoB: The intracellular protein detection dilemma in lipoprotein biology ↗Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2025 · PMID 40953694not yet assessed
-
Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study ↗UNC Libraries · 2025not yet assessed
-
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome ↗New England Journal of Medicine · 2024 · PMID 38587247not yet assessed
-
VLDL Biogenesis and Secretion: It Takes a Village ↗Circulation Research · 2024 · PMID 38236950not yet assessed
-
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism ↗Current Opinion in Lipidology · 2024 · PMID 38465912not yet assessed
-
Dynamic regulation of hepatic lipid metabolism by torsinA and its activators ↗JCI Insight · 2024 · PMID 38194265not yet assessed
-
Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria ↗Journal of clinical lipidology · 2024 · PMID 39848842not yet assessed
-
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans ↗Arteriosclerosis Thrombosis and Vascular Biology · 2024 · PMID 38695168not yet assessed
-
A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME ↗Journal of the American College of Cardiology · 2024not yet assessed
-
160-OR: PI3K Inhibition with Single-Dose Alpelisib as a Model of Insulin Resistance in Healthy Adults ↗Diabetes · 2024not yet assessed
-
Hepatocyte-specific depletion of torsinA causes decreased VLDL secretion, abnormal lipid droplet accumulation in the endoplasmic reticulum, and nonalcoholic steatohepatitis in Chow fed mice ↗Atherosclerosis · 2024not yet assessed
-
Single Dose of Phosphatidylinositol 3-Kinase Inhibitor Alpelisib Induces Insulin Resistance in Healthy Adults: A Randomized Feasibility Study ↗Diabetes · 2024 · PMID 39264822not yet assessed
-
6503 A Randomized, Placebo-Controlled Phase 3 Study of Olezarsen In Patients With Familial Chylomicronemia Syndrome: The Balance Trial ↗Journal of the Endocrine Society · 2024not yet assessed
-
Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes ↗Science · 2023 · PMID 37651538not yet assessed
-
Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort ↗Journal of Lipid Research · 2023 · PMID 36706955not yet assessed
-
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants ↗Diabetes Care · 2023 · PMID 37639669not yet assessed
-
Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study ↗Journal of the American Heart Association · 2023 · PMID 37776200not yet assessed
-
TM6SF2 Determines Both the Degree of Lipidation and the Number of VLDL Particles Secreted by the Liver ↗medRxiv · 2023 · PMID 37425717not yet assessed
-
VLDL Biogenesis and Secretion: It Takes a Village ↗Preprints.org · 2023not yet assessed
-
Effects of Administration of Recombinant Human Lecithin-Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans ↗medRxiv · 2023not yet assessed
-
not yet assessed
-
RATIONALE AND DESIGN OF THE BALANCE STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME ↗Journal of the American College of Cardiology · 2023not yet assessed
-
Contributors ↗Clinical Lipidology · 2023not yet assessed
-
Special Patient Populations ↗Clinical Lipidology · 2023not yet assessed
-
Functional interaction of torsinA and its activators in liver lipid metabolism ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37547008not yet assessed
-
Rationale and Design of the Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen in Patients with Familial Chylomicronemia Syndrome ↗Journal of clinical lipidology · 2023not yet assessed
-
not yet assessed
-
FRI092 Rationale And Design Of The Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Olezarsen In Patients With Familial Chylomicronemia Syndrome ↗Journal of the Endocrine Society · 2023not yet assessed
-
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk ↗New England Journal of Medicine · 2022 · PMID 36342113not yet assessed
-
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3) ↗Arteriosclerosis Thrombosis and Vascular Biology · 2022 · PMID 36579649not yet assessed
-
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins ↗Diabetes & Metabolism Journal · 2022 · PMID 35929170not yet assessed
-
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy ↗Diabetes Care · 2022 · PMID 35238894not yet assessed
-
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease ↗American Journal of Preventive Cardiology · 2022 · PMID 36039183not yet assessed
-
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins ↗Diabetes & Metabolism Journal · 2022 · PMID 36193731not yet assessed
-
Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets ↗Journal of Lipid Research · 2022 · PMID 36100089not yet assessed
-
Complex regulation of fatty liver disease ↗Science · 2022 · PMID 35420931not yet assessed
-
Hepatocytes deficient in nuclear envelope protein lamina-associated polypeptide 1 are an ideal mammalian system to study intranuclear lipid droplets ↗bioRxiv (Cold Spring Harbor Laboratory) · 2022not yet assessed
-
not yet assessed
-
not yet assessed
-
THE EPIGENETIC BET-INHIBITOR APABETALONE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES, ACUTE CORONARY SYNDROME AND AN ELEVATED ANGULO NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE - EXPLORATORY ANALYSIS OF THE BETONMACE TRIAL ↗Journal of the American College of Cardiology · 2022not yet assessed
-
In Memoriam: Dr German A. Camejo (1936–2021) ↗Journal of Lipid Research · 2022not yet assessed
-
not yet assessed
-
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society ↗European Heart Journal · 2021 · PMID 34472586not yet assessed
-
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study ↗Cardiovascular Diabetology · 2021 · PMID 33413345not yet assessed
-
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome ↗Clinical Journal of the American Society of Nephrology · 2021 · PMID 33906908not yet assessed
-
LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials ↗Journal of Lipid Research · 2021 · PMID 34774485not yet assessed
-
Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice ↗Journal of Clinical Investigation · 2021 · PMID 34855620not yet assessed
-
ApoB SURFs a Ride from the ER to the Golgi ↗Cell Metabolism · 2021 · PMID 33535097not yet assessed
-
Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial ↗Cardiovascular Diabetology · 2021 · PMID 34158057not yet assessed
-
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial ↗Journal of Alzheimer s Disease · 2021 · PMID 34459400not yet assessed
-
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides ↗Current Opinion in Lipidology · 2021 · PMID 33883445not yet assessed
-
The year in cardiovascular medicine 2021: dyslipidaemia ↗European Heart Journal · 2021 · PMID 34974612not yet assessed
-
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial ↗Diabetes Care · 2021 · PMID 34785535not yet assessed
-
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials ↗Diabetes Obesity and Metabolism · 2021 · PMID 34463415not yet assessed
-
Patients with raised Lipoprotein(a) are committed to being involved in clinical trials to develop a treatment to lower Lp(a): results of a survey distributed via the Lipoprotein(a) Foundation. ↗Journal of clinical lipidology · 2021not yet assessed
-
Correction: Personalized glucose forecasting for type 2 diabetes using data assimilation ↗PLoS Computational Biology · 2021 · PMID 34415908not yet assessed
-
Abstract P182: Recombinant Human Lecithin-cholesterol Acyltransferase Treatment In Patients With ASCVD Increases HDL Through Increases In Cholesterol Ester Content. ↗Arteriosclerosis Thrombosis and Vascular Biology · 2021not yet assessed
-
Relationship of Plasma ApolipoproteinC3 with Plasma Lipoprotein(a) ↗The FASEB Journal · 2021not yet assessed
-
Relationship between plasma apolipoproteinc3 and plasma lipoprotein(a) levels in a diverse, healthy population ↗Atherosclerosis · 2021not yet assessed
-
not yet assessed
-
Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial ↗European Heart Journal · 2021not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 13534: Plasma Apolipoprotein C3 is Negatively Associated With High Lipoprotein(a) Plasma Levels in Healthy Volunteers ↗Circulation · 2021not yet assessed
-
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel ↗European Heart Journal · 2020 · PMID 32052833not yet assessed
-
Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease ↗Diabetes · 2020 · PMID 32198194not yet assessed
-
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes ↗JAMA · 2020 · PMID 32219359not yet assessed
-
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline ↗The Journal of Clinical Endocrinology & Metabolism · 2020 · PMID 32951056not yet assessed
-
Hypertriglyceridemia—Causes, Significance, and Approaches to Therapy ↗Frontiers in Endocrinology · 2020 · PMID 32982991not yet assessed
-
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine ↗Advanced Functional Materials · 2020 · PMID 33390875not yet assessed
-
Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes ↗Journal of the American College of Cardiology · 2020 · PMID 32029134not yet assessed
-
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid ↗Diabetes · 2020 · PMID 31974142not yet assessed
-
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials ↗Journal of Nutrition · 2020 · PMID 32492148not yet assessed
-
Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes ↗European Heart Journal · 2020not yet assessed
-
Diabetes and Dyslipidemia ↗Endocrinology · 2020not yet assessed
-
THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL ↗Journal of the American College of Cardiology · 2020not yet assessed
-
Monthly hemostatic factor variability in women and men ↗UNC Libraries · 2020not yet assessed
-
Abstract 219: Effects of Homozygosity for the P.e167k Variant in Tm6sf2 on Lipid and Lipoprotein Metabolism in HumansArteriosclerosis Thrombosis and Vascular Biology · 2020not yet assessed
-
Effect of Apabetalone on Major Adverse Cardiovascular Events in Patients with CKD, Diabetes, and Recent Acute Coronary Syndrome: Results from the BETonMACE Trial ↗Journal of the American Society of Nephrology · 2020not yet assessed
-
Reply ↗Journal of the American College of Cardiology · 2020 · PMID 32527410not yet assessed
-
not yet assessed
-
Pemafibrate improves triglyceride metabolism markers in a European population on background statin therapy ↗Atherosclerosis · 2020not yet assessed
-
Dyrk1b Displaces Fkbp12 from mTORC2, Causes its Activation and Triggers De Novo Lipogenesis: Implications for the Treatment of Diet-Induced Fatty Liver Disease ↗SSRN Electronic Journal · 2020not yet assessed
-
Impact of IMPACT: Longitudinal Analysis of an Integrated Participant Scheduling System in a Clinical Research Setting. ↗PubMed · 2020 · PMID 33936400not yet assessed
-
Association of Triglyceride-Lowering <i>LPL</i> Variants and LDL-C–Lowering <i>LDLR</i> Variants With Risk of Coronary Heart Disease ↗JAMA · 2019 · PMID 30694319not yet assessed
-
Clinical review on triglycerides ↗European Heart Journal · 2019 · PMID 31764986not yet assessed
-
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial ↗Circulation · 2019 · PMID 31707832not yet assessed
-
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement ↗The Lancet Diabetes & Endocrinology · 2019 · PMID 31582260not yet assessed
-
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential ↗Cardiovascular Diabetology · 2019 · PMID 31164165not yet assessed
-
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials ↗Atherosclerosis · 2019 · PMID 31253441not yet assessed
-
Nuclear envelope–localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis ↗Journal of Clinical Investigation · 2019 · PMID 31408437not yet assessed
-
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control ↗Atherosclerosis · 2019 · PMID 31349086not yet assessed
-
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia ↗Cardiovascular Drugs and Therapy · 2019 · PMID 30734207not yet assessed
-
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus? ↗Journal of Clinical Investigation · 2019 · PMID 31449060not yet assessed
-
Life is complicated: so is apoCIII ↗Journal of Lipid Research · 2019 · PMID 31239286not yet assessed
-
Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key? ↗Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2019 · PMID 31405699not yet assessed
-
Evolocumab Treatment of Hypercholesterolemia in OSLER-1 ↗Journal of the American College of Cardiology · 2019 · PMID 31648706not yet assessed
-
Selective Trafficking of Fatty Acids in the Liver: Add Them2 to the List of Influencers ↗Hepatology · 2019 · PMID 31155742not yet assessed
-
BET PROTEIN INHIBITION AND COGNITION: A PRE-SPECIFIED SUBSTUDY OF THE BETONMACE PHASE 3 TRIAL EVALUATING APABETALONE IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROME ↗Journal of the American College of Cardiology · 2019not yet assessed
-
Diabetes and Dyslipidemia ↗Endocrinology · 2019not yet assessed
-
Diabetes and Dyslipidemia ↗Endocrinology · 2019not yet assessed
-
Abstract 682: TM6SF2 is Necessary for the Late Addition of Lipid and Secretion of Fully-lipidated Very Low Density Lipoproteins From Hepg2 Cell ↗Arteriosclerosis Thrombosis and Vascular Biology · 2019not yet assessed
-
Abstract 498: A Novel Human <i>APOC2</i> Mutation Causes Severe Hypertriglyceridemia Due to Decreased Fractional Clearance Rates of Very Low Density Lipoprotein apoB and Triglyceride and Increased Production Rates of Very Low Density Lipoprotein Triglyceride ↗Arteriosclerosis Thrombosis and Vascular Biology · 2019not yet assessed
-
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial HypercholesterolemiaSTM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · 2019not yet assessed
-
P4608BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE trial ↗European Heart Journal · 2019not yet assessed
-
Abstract 484: Apolipoprotein (a) Isoform Size Regulates Both the Production and Clearance of Circulating Lipoprotein (a) ↗Arteriosclerosis Thrombosis and Vascular Biology · 2019not yet assessed
-
Abstract 498: A Novel Human APOC2 Mutation Causes Severe Hypertriglyceridemia Due to Decreased Fractional Clearance Rates of Very Low Density Lipoprotein apoB and Triglyceride and Increased Production Rates of Very Low Density Lipoprotein TriglycerideArteriosclerosis Thrombosis and Vascular Biology · 2019not yet assessed
-
Abstract 12948: ALP Levels Predict Adverse Cardiovascular Outcomes and Cognitive Impairment in High Risk PatientsCirculation · 2019not yet assessed
-
Diabetes and Dyslipidemia ↗Endocrinology · 2019not yet assessed
-
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis ↗Journal of the American College of Cardiology · 2018 · PMID 29325642not yet assessed
-
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract ↗European Heart Journal · 2018 · PMID 29718253not yet assessed
-
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study ↗American Heart Journal · 2018 · PMID 30342298not yet assessed
-
Effects of <i>APOC3</i> Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism ↗Arteriosclerosis Thrombosis and Vascular Biology · 2018 · PMID 30580564not yet assessed
-
Progress and perspectives in plant sterol and plant stanol research ↗Nutrition Reviews · 2018 · PMID 30101294not yet assessed
-
Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects ↗Journal of Lipid Research · 2018 · PMID 30293969not yet assessed
-
Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials ↗Journal of the American Heart Association · 2018 · PMID 30371190not yet assessed
-
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies ↗Diabetes Therapy · 2018 · PMID 29779195not yet assessed
-
FoxO transcription factors are required for hepatic HDL cholesterol clearanceJournal of Clinical Investigation · 2018 · PMID 29408809L1 49/100
-
γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor ↗Cell Metabolism · 2018 · PMID 29576536not yet assessed
-
Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials ↗Diabetes Obesity and Metabolism · 2018 · PMID 29493859not yet assessed
-
Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes ↗Diabetes Care · 2018 · PMID 29472432not yet assessed
-
Diabetes and Dislipidemia ↗Endocrinology · 2018not yet assessed
-
Diabetes and Dislipidemia ↗Endocrinology · 2018not yet assessed
-
Loss of function of either LAP1 or torsina, nuclear membrane associated proteins, causes inhibition of VLDL secretion and severe steatohepatitis in chow fed mice ↗Atherosclerosis · 2018not yet assessed
-
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies ↗Figshare · 2018not yet assessed
-
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel ↗European Heart Journal · 2017 · PMID 28444290not yet assessed
-
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk ↗JAMA · 2017 · PMID 28846118not yet assessed
-
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes ↗Diabetes Care · 2017 · PMID 29208654not yet assessed
-
Personalized glucose forecasting for type 2 diabetes using data assimilation ↗PLoS Computational Biology · 2017 · PMID 28448498not yet assessed
-
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects ↗Arteriosclerosis Thrombosis and Vascular Biology · 2017 · PMID 28729361not yet assessed
-
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data ↗European Heart Journal · 2017 · PMID 29186504not yet assessed
-
Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes ↗Current Cardiology Reports · 2017 · PMID 28132397not yet assessed
-
Genetic Variants in <i>HSD17B3</i>, <i>SMAD3</i>, and <i>IPO11</i> Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes ↗Clinical Pharmacology & Therapeutics · 2017 · PMID 28736931not yet assessed
-
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E ↗Journal of Lipid Research · 2017 · PMID 28314859not yet assessed
-
Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study ↗BMJ Open Diabetes Research & Care · 2017 · PMID 28191321not yet assessed
-
Chronic alcohol consumption decreases brown adipose tissue mass and disrupts thermoregulation: a possible role for altered retinoid signaling ↗Scientific Reports · 2017 · PMID 28262768not yet assessed
-
LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN VERY HIGH RISK PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSES FROM THE ODYSSEY TRIALS ↗Journal of the American College of Cardiology · 2017not yet assessed
-
LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN WOMEN: ANALYSES FROM THE ODYSSEY TRIALS OF ALIROCUMAB VERSUS CONTROL ↗Journal of the American College of Cardiology · 2017not yet assessed
-
Increase in apoliporotein-A2 Levels is associated with lower cardiovascular risk in the accord lipid trial ↗Atherosclerosis · 2017not yet assessed
-
Mipomersen treatment decreases lipoprotein (a) plasma levels by increasing its fractional clearance from plasma ↗Atherosclerosis · 2017not yet assessed
-
Abstract 21171: Combinatorial Aso-Mediated Knockdown of ApoB and DGAT2 Inhibits Both VLDL Secretion and High Fat Diet Induced Hepatic Steatosis ↗Circulation · 2017not yet assessed
-
Abstract 21310: ApoCIII RX19 Mutation Lowers the Production of ApoCIII and Increases the Clearance of VLDL-TG ↗Circulation · 2017not yet assessed
-
Abstract 15710: Impact of Age on the Efficacy and Safety of Alirocumab in Patients With Heterozygous Familial HypercholesterolemiaCirculation · 2017not yet assessed
-
Abstract 14549: ApoB Antisense Treatment Increases the Clearance of Apolipoprotein (a) From Mature Lp(a) ParticlesCirculation · 2017not yet assessed
-
Lipidomic and proteomic predictors of drastic reductions of HDL in the accord lipid trial ↗Atherosclerosis · 2017not yet assessed
-
Abstract 190: The Role of Hepatic FoxO Transcription Factors in HDL-Mediated Reverse Cholesterol Transport ↗Arteriosclerosis Thrombosis and Vascular Biology · 2017not yet assessed
-
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans ↗Circulation · 2016 · PMID 27986651not yet assessed
-
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher ↗Cardiovascular Drugs and Therapy · 2016 · PMID 27618825not yet assessed
-
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes ↗JAMA Cardiology · 2016 · PMID 28030716not yet assessed
-
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies ↗European Heart Journal · 2016 · PMID 27460890not yet assessed
-
Reductions in Atherogenic Lipids and Major Cardiovascular Events ↗Circulation · 2016 · PMID 27777279not yet assessed
-
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study ↗Journal of the American Heart Association · 2016 · PMID 27625344not yet assessed
-
Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis ↗Journal of Clinical Investigation · 2016 · PMID 27599291not yet assessed
-
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein ↗Arteriosclerosis Thrombosis and Vascular Biology · 2016 · PMID 26966279not yet assessed
-
Normalization of Hepatic Homeostasis in the Npc1 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat ↗Journal of Biological Chemistry · 2016 · PMID 28031458not yet assessed
-
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans ↗Science Translational Medicine · 2016 · PMID 26819195not yet assessed
-
Type 1 <i>Deiodinase</i> Regulates <i>ApoA-I</i> Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling ↗Arteriosclerosis Thrombosis and Vascular Biology · 2016 · PMID 27150392not yet assessed
-
Lipid changes during basal insulin peglispro, insulin glargine, or <scp>NPH</scp> treatment in six <scp>IMAGINE</scp> trials ↗Diabetes Obesity and Metabolism · 2016 · PMID 27486125not yet assessed
-
Lipoprotein (a): Coming of Age at Last ↗Journal of Lipid Research · 2016 · PMID 26839334not yet assessed
-
Impaired postprandial lipemic response in chronic kidney disease ↗Kidney International · 2016 · PMID 27162092not yet assessed
-
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects ↗Journal of Clinical Investigation · 2016not yet assessed
-
RELATIONSHIP BETWEEN MAJOR ADVERSE CARDIOVASCULAR EVENTS AND ACHIEVED LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN PHASE 3 ODYSSEY TRIALS OF ALIROCUMAB VERSUS CONTROL ↗Journal of the American College of Cardiology · 2016not yet assessed
-
Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation ↗HIV Clinical Trials · 2016 · PMID 27077672not yet assessed
-
RELATIONSHIP BETWEEN PERCENTAGE REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG PATIENTS TREATED WITH STATINS +/- ALIROCUMAB OR EZETIMIBE IN THE PHASE 3 ODYSSEY TRIALS ↗Journal of the American College of Cardiology · 2016not yet assessed
-
Abstract 18484: Modest Potential Association Between Reductions in Lipoprotein(a) and Major Adverse Cardiovascular Events in the Phase 3 Trials of Alirocumab versus ControlCirculation · 2016not yet assessed
-
Abstract #504: Alirocumab Efficacy and Safety In Individuals with Metabolic Syndrome: Pooled Data From Phase 3 Trials ↗Endocrine Practice · 2016not yet assessed
-
EFFICACY AND SAFETY OF ALIROCUMAB STRATIFIED BY AGE IN PHASE 3 TRIALS ↗Journal of the American College of Cardiology · 2016not yet assessed
-
Inverse Relationship Between Major Adverse Cardiovascular Events and non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in Phase 3 Trials of Alirocumab ↗Journal of clinical lipidology · 2016not yet assessed
-
Abstract 16398: Effect of CETP Inhibition With Anacetrapib on VLDL Triglyceride and Plasma ApoC-II, ApoC-III and ApoE MetabolismCirculation · 2016not yet assessed
-
Abstract #294: Potential Relevance of Changes in Hematocrit to Changes in Lipid Parameters with Empagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) ↗Endocrine Practice · 2016not yet assessed
-
Abstract 16512: Alirocumab Treatment Was Not Associated With a Higher Risk of Neurocognitive Events in 3340 High and Very High Cardiovascular Risk PatientsCirculation · 2016not yet assessed
-
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management ↗European Heart Journal · 2015 · PMID 25694464not yet assessed
-
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment ↗European Heart Journal · 2015 · PMID 26009596not yet assessed
-
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia ↗European Heart Journal · 2015 · PMID 26330422not yet assessed
-
Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü2015not yet assessed
-
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects ↗Journal of Clinical Investigation · 2015 · PMID 25961461not yet assessed
-
Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From <i>ATVB</i> Council ↗Arteriosclerosis Thrombosis and Vascular Biology · 2015 · PMID 26376908not yet assessed
-
PCSK9 inhibitors and cardiovascular disease ↗Current Opinion in Lipidology · 2015 · PMID 26780005not yet assessed
-
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone ↗Molecular & Cellular Proteomics · 2015 · PMID 26667175not yet assessed
-
Special Patient Populations ↗Clinical Lipidology · 2015not yet assessed
-
not yet assessed
-
Abstract 16863: Alirocumab Effect on Glycemic Measures in Patients Without Diabetes at Baseline ↗Circulation · 2015not yet assessed
-
Abstract 15997: The Effect of Combined Statin/Fibrate Therapy on Cardiovascular Disease is Influenced by Sex and Dyslipidemia: ACCORDION-Lipid Long-Term Follow-up ↗Circulation · 2015not yet assessed
-
Abstract 18390: Effects of a Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor, Alirocumab, on Lipid and Lipoprotein Metabolism in Healthy Subjects ↗Circulation · 2015not yet assessed
-
not yet assessed
-
Abstract 129: Effects of a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor, Alirocumab, on Lipid and Lipoprotein Metabolism in Normal Subjects ↗Arteriosclerosis Thrombosis and Vascular Biology · 2015not yet assessed
-
Contributors ↗Clinical Lipidology · 2015not yet assessed
-
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society ↗European Heart Journal · 2014 · PMID 25053660not yet assessed
-
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial ↗International Journal of Cardiology · 2014 · PMID 25037695not yet assessed
-
Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials) ↗The American Journal of Cardiology · 2014 · PMID 25060413not yet assessed
-
Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels ↗JAMA Internal Medicine · 2014 · PMID 24493100not yet assessed
-
Residual macrovascular risk in 2013: what have we learned? ↗Cardiovascular Diabetology · 2014 · PMID 24460800not yet assessed
-
The Combined Hyperlipidemia Caused by Impaired Wnt-LRP6 Signaling Is Reversed by Wnt3a Rescue ↗Cell Metabolism · 2014 · PMID 24506864not yet assessed
-
The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice ↗Atherosclerosis Supplements · 2014 · PMID 24840509not yet assessed
-
Gerald M. Reaven, MD: Demonstration of the Central Role of Insulin Resistance in Type 2 Diabetes and Cardiovascular Disease ↗Diabetes Care · 2014 · PMID 24757223not yet assessed
-
Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure ↗Journal of Biological Chemistry · 2014 · PMID 25157099not yet assessed
-
Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins ↗Clinical Chemistry · 2014 · PMID 24751376not yet assessed
-
The 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol ↗Circulation Research · 2014 · PMID 24577964not yet assessed
-
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS ↗Journal of Lipid Research · 2014 · PMID 24694356not yet assessed
-
A 24-WEEK STUDY OF ALIROCUMAB AS MONOTHERAPY VERSUS EZETIMIBE: THE FIRST PHASE 3 DATA OF A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITOR ↗Journal of the American College of Cardiology · 2014not yet assessed
-
Monthly haemostatic factor variability in women and men ↗European Journal of Clinical Investigation · 2014 · PMID 24382103not yet assessed
-
Relationship between alirocumab, PCSK9 and LDL-C levels: results from the odyssey mono phase 3 trial of alirocumab 75 mg every 2 weeks ↗Atherosclerosis · 2014not yet assessed
-
Autophagy and cardiometabolic risk factors ↗Reviews in Endocrine and Metabolic Disorders · 2014 · PMID 25246308not yet assessed
-
Abstract 17736: Cardiomyocyte Specific Loss of Diacylglycerol Acyl Transferase 1 (Dgat1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure ↗Circulation · 2014not yet assessed
-
Abstract 634: Treatment with Mipomersen Reduces Levels of ApoB-Containing Lipoproteins by Increasing Fractional Removal of VLDL and LDL-apoB Without Reducing VLDL-apob Secretion ↗Arteriosclerosis Thrombosis and Vascular Biology · 2014not yet assessed
-
Treatment of severe hypertriglyceridaemia – Authors' reply ↗The Lancet Diabetes & Endocrinology · 2014 · PMID 25439460not yet assessed
-
Abstract 628: Hepatic Insulin Signaling Regulates ApoA-I Gene Expression Through the Type I Deiodinase. ↗Arteriosclerosis Thrombosis and Vascular Biology · 2014not yet assessed
-
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society ↗European Heart Journal · 2013 · PMID 23956253not yet assessed
-
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management ↗The Lancet Diabetes & Endocrinology · 2013 · PMID 24731657not yet assessed
-
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease ↗Atherosclerosis · 2013 · PMID 24468148not yet assessed
-
Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability ↗Nature Medicine · 2013 · PMID 23832089not yet assessed
-
Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial ↗Diabetes Care · 2013 · PMID 24170759not yet assessed
-
Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue ↗Journal of Lipid Research · 2013 · PMID 24186946not yet assessed
-
Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry ↗Rapid Communications in Mass Spectrometry · 2013 · PMID 23681806not yet assessed
-
Niacin ↗Current Opinion in Lipidology · 2013 · PMID 24184940not yet assessed
-
Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial ↗PLoS ONE · 2013 · PMID 23593417not yet assessed
-
Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial ↗Diabetes Care · 2013 · PMID 24296848not yet assessed
-
Alirocumab, a Fully Human Monoclonal Antibody to Proprotein Convertase Subtilisin/kexin Type 9: Therapeutic Dosing in Phase 3 Studies ↗Journal of clinical lipidology · 2013not yet assessed
-
Statins in cardiometabolic disease: what makes pitavastatin different? ↗Cardiovascular Diabetology · 2013 · PMID 23819727not yet assessed
-
Abstract 118: The Effect of CETP Inhibition With Anacetrapib on the Metabolism of PCSK9 ↗Arteriosclerosis Thrombosis and Vascular Biology · 2013not yet assessed
-
Linking Clinical Care and Community Interventions in Diabetes Prevention and Management2013not yet assessed
-
Regulation of Plasma Lipoprotein Levels in Humans: New Insights Using Methods Pioneered by Bob Levy ↗Circulation · 2013not yet assessed
-
CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status ↗Diabetes · 2012 · PMID 22474027not yet assessed
-
Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants ↗Diabetes Care · 2012 · PMID 22432114not yet assessed
-
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice ↗Journal of Clinical Investigation · 2012 · PMID 22466652not yet assessed
-
Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying ↗Journal of Lipid Research · 2012 · PMID 22911105not yet assessed
-
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience ↗Diabetologia · 2012 · PMID 22450889not yet assessed
-
Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial ↗Diabetes Care · 2012 · PMID 23033246not yet assessed
-
Abstract 14725: Effect of SAR236553/REGN727 Fully Human Monoclonal Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Antibody on Plasma Lipoprotein(a) Concentrations: Pooled Analysis from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443)Circulation · 2012not yet assessed
-
Abstract 16127: Effect of REGN727/SAR236553 Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Fully Human Monoclonal Antibody in Patients with Elevated Triglycerides/Low High-Density Lipoprotein Cholesterol: Data from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443)Circulation · 2012not yet assessed
-
of Fenofibrate Therapy- Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants2012not yet assessed
-
Abstract 25: Inhibition of VLDL Assembly by Apolipoprotein B Antisense Oligonucleotides Stimulates Autophagy ↗Arteriosclerosis Thrombosis and Vascular Biology · 2012not yet assessed
-
Abstract 329: Mechanism by Which Anacetrapib Lowers Plasma Lipoprotein (a) Concentration ↗Arteriosclerosis Thrombosis and Vascular Biology · 2012not yet assessed
-
Abstract 506: Hepatic Insulin Signaling Regulates ApoAI Expression Through Type I Deiodinase ↗Arteriosclerosis Thrombosis and Vascular Biology · 2012not yet assessed
-
Apoprotein B: quality control early and late in the secretory pathway for this atherogenic protein ↗The FASEB Journal · 2012not yet assessed
-
Triglycerides and Cardiovascular Disease ↗Circulation · 2011 · PMID 21502576not yet assessed
-
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management ↗European Heart Journal · 2011 · PMID 21531743not yet assessed
-
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance ↗Trends in Endocrinology and Metabolism · 2011 · PMID 21616678not yet assessed
-
32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT ↗Atherosclerosis Supplements · 2011not yet assessed
-
Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy ↗Journal of Lipid Research · 2011 · PMID 21719579not yet assessed
-
The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus ↗Clinical Lipidology · 2011 · PMID 26207146not yet assessed
-
The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial ↗Diabetes Care · 2011 · PMID 21525439not yet assessed
-
DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle ↗Journal of Lipid Research · 2011 · PMID 21205704not yet assessed
-
Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism ↗Journal of Lipid Research · 2011 · PMID 21364201not yet assessed
-
Apolipoprotein B Secretion Is Regulated by Hepatic Triglyceride, and Not Insulin, in a Model of Increased Hepatic Insulin Signaling ↗Arteriosclerosis Thrombosis and Vascular Biology · 2011 · PMID 22155452not yet assessed
-
Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus ↗Expert Opinion on Pharmacotherapy · 2011 · PMID 21426238not yet assessed
-
Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet ↗Metabolism · 2011 · PMID 22209663not yet assessed
-
Triglycerides and Cardiovascular Disease : A Scientific Statement From the2011not yet assessed
-
Apolipoprotein CIII ↗Arteriosclerosis Thrombosis and Vascular Biology · 2011 · PMID 21325666not yet assessed
-
Lipoprotein(a) as a cardiovascular risk factor: current status ↗European Heart Journal · 2010 · PMID 20965889not yet assessed
-
C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis ↗Diabetes · 2010 · PMID 20103702not yet assessed
-
Short Sleep Duration as a Risk Factor for Hypercholesterolemia: Analyses of the National Longitudinal Study of Adolescent Health ↗SLEEP · 2010 · PMID 20614855not yet assessed
-
Improved Diabetic Control in Advanced Heart Failure Patients Treated with Left Ventricular Assist Devices ↗European Journal of Heart Failure · 2010 · PMID 21098576not yet assessed
-
Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective ↗Current Opinion in Lipidology · 2010 · PMID 21102326not yet assessed
-
Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus ↗Metabolism · 2010 · PMID 20102776not yet assessed
-
Residual Risk Reduction Initiative: výzva ke snížení reziduálního vaskulárního rizika u pacientů s dyslipidemií ↗Cor et Vasa · 2010not yet assessed
-
Targeting ApoB as a therapeutic approach for the treatment of dyslipidemia: the potential role of mipomersen ↗Clinical Lipidology · 2010not yet assessed
-
Abstract 19724: Hypertriglyceridemia and Low HDL-C Predicts Fenofibrate Response in The ACCORD-Lipid TrialCirculation · 2010not yet assessed
-
Abstract 20114: Effect of Fenofibrate Therapy on Cardiovascular Disease in Men versus Women with Type 2 Diabetes in the ACCORD-Lipid TrialCirculation · 2010not yet assessed
-
Faculty Opinions recommendation of From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2010not yet assessed
-
The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes Mellitus ↗Journal of the CardioMetabolic Syndrome · 2009 · PMID 19614799not yet assessed
-
Adipose tissue distribution after weight restoration and weight maintenance in women with anorexia nervosa ↗American Journal of Clinical Nutrition · 2009 · PMID 19793856not yet assessed
-
The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: II. Therapeutic Management of Atherogenic Dyslipidemia ↗Journal of Clinical Hypertension · 2009 · PMID 19751468not yet assessed
-
Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus ↗Journal of Lipid Research · 2009 · PMID 19429886not yet assessed
-
Development of Apolipoprotein B Antisense Molecules as a Therapy for Hyperlipidemia ↗Current Atherosclerosis Reports · 2009 · PMID 20425272not yet assessed
-
The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk ↗Obesity · 2009 · PMID 19373218not yet assessed
-
Special Patient Populations: Diabetes and Metabolic Syndrome ↗Clinical Lipidology · 2009not yet assessed
-
Abstract: S4-6 HEPATIC EFFECTS OF APOB ANTISENSE ↗Atherosclerosis Supplements · 2009not yet assessed
-
Abstract: 1450 USE OF COMBINED LIPID LOWERING AND GLUCOSE LOWERING THERAPY IN DIABETES MELLITUS. ↗Atherosclerosis Supplements · 2009not yet assessed
-
Contributing Authors ↗Clinical Lipidology · 2009not yet assessed
-
Faculty Opinions recommendation of A randomized trial of therapies for type 2 diabetes and coronary artery disease. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2009not yet assessed
-
Faculty Opinions recommendation of Extended-release niacin or ezetimibe and carotid intima-media thickness. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2009not yet assessed
-
Faculty Opinions recommendation of Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2009not yet assessed
-
The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia ↗The American Journal of Cardiology · 2008 · PMID 19068318not yet assessed
-
Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis ↗Cell Metabolism · 2008 · PMID 18249172not yet assessed
-
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents ↗Journal of Clinical Investigation · 2008 · PMID 18060040not yet assessed
-
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients ↗Diabetes and Vascular Disease Research · 2008 · PMID 18958843not yet assessed
-
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism ↗Journal of Lipid Research · 2008 · PMID 19050312not yet assessed
-
Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease ↗The American Journal of Cardiology · 2008 · PMID 18359322not yet assessed
-
Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia ↗The American Journal of Cardiology · 2008 · PMID 18929706not yet assessed
-
Insulin Resistance and Dyslipidemia ↗Humana Press eBooks · 2008not yet assessed
-
Kinetic Studies of the Metabolism of Rapidly Exchangeable Apolipoproteins May Leave Investigators and Readers With Exchangeable Results ↗Arteriosclerosis Thrombosis and Vascular Biology · 2008 · PMID 18799794not yet assessed
-
Faculty Opinions recommendation of Regulation of hepatic lipogenesis by the transcription factor XBP1. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Faculty Opinions recommendation of Effects of torcetrapib in patients at high risk for coronary events. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Faculty Opinions recommendation of Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Faculty Opinions recommendation of Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Faculty Opinions recommendation of A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Faculty Opinions recommendation of Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008not yet assessed
-
Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study ↗Clinical Therapeutics · 2007 · PMID 17825687not yet assessed
-
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial ↗The American Journal of Cardiology · 2007 · PMID 17599424not yet assessed
-
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states ↗American Journal of Clinical Nutrition · 2007 · PMID 18065577not yet assessed
-
Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial ↗The American Journal of Cardiology · 2007 · PMID 17599426not yet assessed
-
Lipoprotein metabolism in chronic renal insufficiency ↗Pediatric Nephrology · 2007 · PMID 17390152not yet assessed
-
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states ↗American Journal of Clinical Nutrition · 2007not yet assessed
-
Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistance ↗Metabolism · 2007 · PMID 17950109not yet assessed
-
Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance ↗Journal of Lipid Research · 2007 · PMID 18089891not yet assessed
-
Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice ↗Journal of Lipid Research · 2007 · PMID 17277355not yet assessed
-
Faculty Opinions recommendation of Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007not yet assessed
-
Faculty Opinions recommendation of Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007not yet assessed
-
Faculty Opinions recommendation of Optimal medical therapy with or without PCI for stable coronary disease. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007not yet assessed
-
Faculty Opinions recommendation of Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007not yet assessed
-
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus ↗Diabetes Care · 2006 · PMID 17192355not yet assessed
-
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus ↗Circulation · 2006 · PMID 17192512not yet assessed
-
Metabolic Syndrome: Focus on Dyslipidemia ↗Obesity · 2006 · PMID 16642962not yet assessed
-
Diabetic Dyslipidemia ↗Endocrinology and Metabolism Clinics of North America · 2006 · PMID 16959582not yet assessed
-
Aberrant Hepatic Expression of PPARγ2 Stimulates Hepatic Lipogenesis in a Mouse Model of Obesity, Insulin Resistance, Dyslipidemia, and Hepatic Steatosis ↗Journal of Biological Chemistry · 2006 · PMID 16971390not yet assessed
-
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia ↗The Journal of Clinical Endocrinology & Metabolism · 2006 · PMID 16291700not yet assessed
-
Ins and Outs Modulating Hepatic Triglyceride and Development of Nonalcoholic Fatty Liver Disease ↗Gastroenterology · 2006 · PMID 16618425not yet assessed
-
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol? ↗Cell Metabolism · 2006 · PMID 16950134not yet assessed
-
Translocation Efficiency of Apolipoprotein B Is Determined by the Presence of β-Sheet Domains, Not Pause Transfer Sequences ↗Journal of Biological Chemistry · 2006 · PMID 16854991not yet assessed
-
Niacin in the metabolic syndrome: more risk than benefit? ↗Nature Clinical Practice Endocrinology & Metabolism · 2006 · PMID 16932303not yet assessed
-
Cholesterol Management: Targeting a Lower Low-Density Lipoprotein Cholesterol Concentration Increases Adult Treatment Panel-III Goal Attainment ↗The American Journal of Cardiology · 2006 · PMID 16728235not yet assessed
-
Mo-W3:3 VLDL secretion and catabolism in insulin resistance and type 2 diabetes mellitus ↗Atherosclerosis Supplements · 2006not yet assessed
-
An ARC light on lipid metabolism2006not yet assessed
-
The JLR opens up its heart (and liver, fat, muscle) to patient-oriented research ↗Journal of Lipid Research · 2006not yet assessed
-
Faculty Opinions recommendation of Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2006not yet assessed
-
Faculty Opinions recommendation of Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. ↗Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2006not yet assessed
-
not yet assessed
-
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes ↗Archives of Medical Research · 2005 · PMID 15925013not yet assessed
-
Adipocyte Signaling and Lipid Homeostasis ↗Circulation Research · 2005 · PMID 15920027not yet assessed
-
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus ↗Journal of Clinical Investigation · 2005 · PMID 15841215not yet assessed
-
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus ↗Journal of Clinical Investigation · 2005not yet assessed
-
Cholesterol-Lowering Benefits of Oat-Containing Cereal in Hispanic Americans ↗Journal of the American Dietetic Association · 2005 · PMID 15942550not yet assessed
-
Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue ↗Diabetes · 2005 · PMID 16306352not yet assessed
-
Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia ↗Journal of Lipid Research · 2005 · PMID 16162940not yet assessed
-
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy ↗American Journal of Clinical Nutrition · 2005 · PMID 16002813not yet assessed
-
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy ↗American Journal of Clinical Nutrition · 2005not yet assessed
-
Diabetes and Dyslipidemia ↗Humana Press eBooks · 2005not yet assessed
-
Managing Dyslipidemia and Global Risk in Patients with Type 2 Diabetes and Insulin Resistance Managing Dyslipidemia and Global Risk in Patients with Type 2 Diabetes and Insulin Resistance2005not yet assessed
-
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production ↗Journal of Clinical Investigation · 2004 · PMID 15124019not yet assessed
-
Overexpression of Human Diacylglycerol Acyltransferase 1, Acyl-CoA:Cholesterol Acyltransferase 1, or Acyl-CoA:Cholesterol Acyltransferase 2 Stimulates Secretion of Apolipoprotein B-containing Lipoproteins in McA-RH7777 Cells ↗Journal of Biological Chemistry · 2004 · PMID 15308631not yet assessed
-
Regulation of Hepatic Apolipoprotein B-lipoprotein Assembly and Secretion by the Availability of Fatty Acids ↗Journal of Biological Chemistry · 2004 · PMID 14970200not yet assessed
-
The role of acyl‐CoA:diacylglycerol acyltransferase (DGAT) in energy metabolism ↗Annals of Medicine · 2004 · PMID 15224651not yet assessed
-
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production ↗Journal of Clinical Investigation · 2004not yet assessed
-
The Prove It Study: Is It Really a Landmark Study or Another Piece of a Very Important Puzzle? ↗Clinical Diabetes · 2004not yet assessed
-
Overexpression of the Tumor Autocrine Motility Factor Receptor Gp78, a Ubiquitin Protein Ligase, Results in Increased Ubiquitinylation and Decreased Secretion of Apolipoprotein B100 in HepG2 Cells ↗Journal of Biological Chemistry · 2003 · PMID 12670940not yet assessed
-
Treatment for patients with the metabolic syndrome ↗The American Journal of Cardiology · 2003 · PMID 12679201not yet assessed
-
The Conversion of ApoB100 Low Density Lipoprotein/High Density Lipoprotein Particles to ApoB100 Very Low Density Lipoproteins in Response to Oleic Acid Occurs in the Endoplasmic Reticulum and Not in the Golgi in McA RH7777 Cells ↗Journal of Biological Chemistry · 2003 · PMID 12917397not yet assessed
-
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. ↗PubMed · 2003 · PMID 12668909not yet assessed
-
The Metabolic Syndrome: Targeting Dyslipidaemia to Reduce Coronary Risk ↗European Journal of Cardiovascular Prevention & Rehabilitation · 2003not yet assessed
-
\nThe metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. ↗Journal of Cardiovascular Risk · 2003not yet assessed
-
Ovariectomy leads to increased insulin resistance in human apolipoprotein B transgenic mice lacking brown adipose tissue ↗Metabolism · 2003 · PMID 12800087not yet assessed
-
Diabetes and Dyslipidemia ↗Humana Press eBooks · 2003not yet assessed
-
not yet assessed
-
Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins ↗Journal of Biological Chemistry · 2002 · PMID 12006608not yet assessed
-
New Perspectives on Atherogenesis ↗Circulation · 2002 · PMID 12379586not yet assessed
-
The Late Addition of Core Lipids to Nascent Apolipoprotein B100, Resulting in the Assembly and Secretion of Triglyceride-rich Lipoproteins, Is Independent of Both Microsomal Triglyceride Transfer Protein Activity and New Triglyceride Synthesis ↗Journal of Biological Chemistry · 2002 · PMID 11704664not yet assessed
-
Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management ↗Current Opinion in Pediatrics · 2002 · PMID 11981290not yet assessed
-
Posttranscriptional Control of the Expression and Function of Diacylglycerol Acyltransferase-1 in Mouse Adipocytes ↗Journal of Biological Chemistry · 2002 · PMID 12407108not yet assessed
-
Risk factors common to insulin resistance and atherosclerosis explain why diabetes is a cardiovascular disease. ↗PubMed · 2002 · PMID 11833454not yet assessed
-
Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized. ↗PubMed · 2002 · PMID 11833457not yet assessed
-
Reply to 'Dyslipidemia due to retroviral protease inhibitors' ↗Nature Medicine · 2002not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia ↗Nature Medicine · 2001 · PMID 11726973not yet assessed
-
Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus ↗The American Journal of Cardiology · 2001 · PMID 11576520not yet assessed
-
Co-translational Interactions of Apoprotein B with the Ribosome and Translocon during Lipoprotein Assembly or Targeting to the Proteasome ↗Journal of Biological Chemistry · 2001 · PMID 11022045not yet assessed
-
Diabetes and dyslipidemia ↗Current Diabetes Reports · 2001 · PMID 12634894not yet assessed
-
Post-transcriptional Stimulation of the Assembly and Secretion of Triglyceride-rich Apolipoprotein B Lipoproteins in a Mouse with Selective Deficiency of Brown Adipose Tissue, Obesity, and Insulin Resistance ↗Journal of Biological Chemistry · 2001 · PMID 11598138not yet assessed
-
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy ↗The American Journal of Cardiology · 2001 · PMID 11356393not yet assessed
-
Microsomal Triglyceride Transfer Protein Binding and Lipid Transfer Activities Are Independent of Each Other, but Both Are Required for Secretion of Apolipoprotein B Lipoproteins from Liver Cells ↗Journal of Biological Chemistry · 2001 · PMID 11358959not yet assessed
-
Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia University BioMarkers Study ↗PEDIATRICS · 2001 · PMID 11533368not yet assessed
-
Variation in the Human ApoB Signal Peptide Modulates ApoB17 Translocation ↗Biochemical and Biophysical Research Communications · 2001 · PMID 11322782not yet assessed
-
The Pancreas and Lipoprotein Metabolism ↗Comprehensive physiology · 2001not yet assessed
-
The Pancreas and Lipoprotein Metabolism ↗Comprehensive physiology · 2001not yet assessed
-
Insulin resistance and cardiovascular disease ↗Journal of Clinical Investigation · 2000 · PMID 10953019not yet assessed
-
Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes ↗Arteriosclerosis Thrombosis and Vascular Biology · 2000 · PMID 10978246not yet assessed
-
The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis ↗European Journal of Cardiovascular Prevention & Rehabilitation · 2000 · PMID 11143762not yet assessed
-
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia ↗American Journal of Clinical Nutrition · 2000 · PMID 10837282not yet assessed
-
The Amino-terminal Domain of Apolipoprotein B Does Not Undergo Retrograde Translocation from the Endoplasmic Reticulum to the Cytosol ↗Journal of Biological Chemistry · 2000 · PMID 10922368not yet assessed
-
Nonpharmacologic management of low levels of high-density lipoprotein cholesterol ↗The American Journal of Cardiology · 2000 · PMID 11374855not yet assessed
-
Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study ↗American Journal of Clinical Nutrition · 2000 · PMID 11063438not yet assessed
-
Biosynthesis of lipoproteins ↗Atherosclerosis · 2000not yet assessed
-
Inhibition of Translocation of Nascent Apolipoprotein B across the Endoplasmic Reticulum Membrane Is Associated with Selective Inhibition of the Synthesis of Apolipoprotein B ↗Journal of Biological Chemistry · 2000not yet assessed
-
Circulating Lipoprotein Profiles are Modulated Differently by Lipoprotein Lipase in Obese Humans ↗European Journal of Cardiovascular Prevention & Rehabilitation · 2000 · PMID 10785873not yet assessed
-
not yet assessed
-
A Review of Metabolic and Cardiovascular Effects of Oral Antidiabetic Agents: Beyond Glucose-Level Lowering ↗European Journal of Cardiovascular Prevention & Rehabilitation · 1999 · PMID 10534139not yet assessed
-
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects ↗American Journal of Clinical Nutrition · 1999 · PMID 10584043not yet assessed
-
Introduction and overview ↗The American Journal of Cardiology · 1999not yet assessed
-
Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects ↗Arteriosclerosis Thrombosis and Vascular Biology · 1998 · PMID 9514413not yet assessed
-
LIPOPROTEIN PHYSIOLOGY ↗Endocrinology and Metabolism Clinics of North America · 1998 · PMID 9785050not yet assessed
-
Effects of Statins on Triglyceride Metabolism ↗The American Journal of Cardiology · 1998 · PMID 9526811not yet assessed
-
Regulated Co-translational Ubiquitination of Apolipoprotein B100 ↗Journal of Biological Chemistry · 1998 · PMID 9733761not yet assessed
-
Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence ↗Proceedings of the National Academy of Sciences · 1998 · PMID 9843958not yet assessed
-
Translocation Efficiency, Susceptibility to Proteasomal Degradation, and Lipid Responsiveness of Apolipoprotein B Are Determined by the Presence of β Sheet Domains ↗Journal of Biological Chemistry · 1998 · PMID 9857060not yet assessed
-
LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics ↗Journal of Lipid Research · 1998 · PMID 9643350not yet assessed
-
Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach ↗Journal of Lipid Research · 1998 · PMID 9555954not yet assessed
-
Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis ↗Journal of Lipid Research · 1998 · PMID 9799814not yet assessed
-
Lipid metabolism: new approaches to old problems ↗Current Opinion in Lipidology · 1998 · PMID 9645499not yet assessed
-
Hypertriglyceridemia and Atherosclerosis ↗Annals of Internal Medicine · 1998not yet assessed
-
Safety and Efficacy of Omacor in Severe Hypertriglyceridemia ↗European Journal of Cardiovascular Prevention & Rehabilitation · 1997 · PMID 9865671not yet assessed
-
Safety and efficacy of Omacor in severe hypertriglyceridemia ↗Journal of Cardiovascular Risk · 1997not yet assessed
-
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70 ↗Journal of Biological Chemistry · 1997 · PMID 9252351not yet assessed
-
A Two-site Model for ApoB Degradation in HepG2 Cells ↗Journal of Biological Chemistry · 1997 · PMID 9111073not yet assessed
-
ROLE OF LIPID SYNTHESIS, CHAPERONE PROTEINS AND PROTEASOMES IN THE ASSEMBLY AND SECRETION OF APOPROTEIN B‐CONTAINING LIPOPROTEINS FROM CULTURED LIVER CELLS ↗Clinical and Experimental Pharmacology and Physiology · 1997 · PMID 9143794not yet assessed
-
Is Hypertriglyceridemia a Risk Factor for Atherosclerotic Cardiovascular Disease? A Simple Question with a Complicated Answer ↗Annals of Internal Medicine · 1997 · PMID 9163295not yet assessed
-
ApoE Genotype Does Not Predict Lipid Response to Changes in Dietary Saturated Fatty Acids in a Heterogeneous Normolipidemic Population ↗Arteriosclerosis Thrombosis and Vascular Biology · 1997 · PMID 9409276not yet assessed
-
Demonstration of Biphasic Effects of Docosahexaenoic Acid on Apolipoprotein B Secretion in HepG2 Cells ↗Arteriosclerosis Thrombosis and Vascular Biology · 1997 · PMID 9409332not yet assessed
-
1.P.230 Variations in the human apolipoprotein B signal peptide alter apoB secretion and degradation in McArdle RH-7777 rat hepatoma cells ↗Atherosclerosis · 1997not yet assessed
-
1.P.267 LPL-93G promoter mutation influences both baseline plasma triglycerides and postprandial response in black and hispanics ↗Atherosclerosis · 1997not yet assessed
-
Diabetic Dyslipidemia: Basic Mechanisms Underlying the Common Hypertriglyceridemia and Low HDL Cholesterol Levels ↗Diabetes · 1996 · PMID 8674885not yet assessed
-
Demonstration of a Physical Interaction between Microsomal Triglyceride Transfer Protein and Apolipoprotein B during the Assembly of ApoB-containing Lipoproteins ↗Journal of Biological Chemistry · 1996 · PMID 8626595not yet assessed
-
Evidence That a Rapidly Turning Over Protein, Normally Degraded by Proteasomes, Regulates hsp72 Gene Transcription in HepG2 Cells ↗Journal of Biological Chemistry · 1996 · PMID 8798747not yet assessed
-
Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a “secretion-coupled” pool. ↗Journal of Lipid Research · 1996 · PMID 8808754not yet assessed
-
EFFECT OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE III HYPERLIPOPROTEINEMIA ↗American Journal of Therapeutics · 1996 · PMID 11862234not yet assessed
-
Cyclosporine, Plasma Lipids, and Organ Transplantation ↗Hepatology · 1996 · PMID 8781351not yet assessed
-
Effect of SCH 48461 on oral cholesterol absorption. ↗Clinical Pharmacology & Therapeutics · 1996not yet assessed
-
Increases in Dietary Cholesterol Are Associated With Modest Increases in Both LDL and HDL Cholesterol in Healthy Young Women ↗Arteriosclerosis Thrombosis and Vascular Biology · 1995 · PMID 7749822not yet assessed
-
Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-Induced Myocardial Ischemia in Middle-Aged Men and Women ↗Arteriosclerosis Thrombosis and Vascular Biology · 1995 · PMID 7583562not yet assessed
-
New Directions in Dietary Studies and Heart Disease: The National Heart, Lung and Blood Institute Sponsored Multicenter Study of Diet Effects on Lipoproteins and Thrombogenic Activity ↗Advances in experimental medicine and biology · 1995 · PMID 7598013not yet assessed
-
Apoprotein B100, an Inefficiently Translocated Secretory Protein, Is Bound to the Cytosolic Chaperone, Heat Shock Protein 70 ↗Journal of Biological Chemistry · 1995 · PMID 7559659not yet assessed
-
Update on the treatment of hypercholesterolemia, with a focus on hmg‐coa reductase inhibitors and combination regimens ↗Clinical Cardiology · 1995 · PMID 7664504not yet assessed
-
Zinc Supplementation During Pregnancy ↗JAMA · 1995 · PMID 8568976not yet assessed
-
EDITORIAL REVIEW: Nutrition and therapeutics: where we are and where we should be going ↗Current Opinion in Lipidology · 1995not yet assessed
-
Low HDL Cholesterol: What Are the Prospects of Increasing It? ↗Annals of Medicine · 1995 · PMID 7546614not yet assessed
-
Lipoprotein metabolism and its relationship to atherosclerosis ↗Medical Clinics of North America · 1994 · PMID 8283926not yet assessed
-
Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. ↗Journal of Lipid Research · 1994 · PMID 7964181not yet assessed
-
Effects of increasing dietary polyunsaturated fatty acids within the guidelines of the AHA step 1 diet on plasma lipid and lipoprotein levels in normal males. ↗Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1994 · PMID 8199179not yet assessed
-
Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. ↗Journal of Biological Chemistry · 1994 · PMID 8163541not yet assessed
-
Regulation of hepatic secretion of lipoproteins ↗Atherosclerosis · 1994not yet assessed
-
The n-3 fatty acid, docosahexaenoic acid, stimulates the secretion of apo B-100-containing lipoproteins from HepG2 cells: further evidence for a critical role of newly synthesized triglyceride ↗Atherosclerosis · 1994not yet assessed
-
The apolipoprotein ε4 allele in patients with Alzheimer's disease ↗Annals of Neurology · 1993 · PMID 8239575not yet assessed
-
Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. ↗Journal of Clinical Investigation · 1993 · PMID 8473514not yet assessed
-
Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. ↗Journal of Biological Chemistry · 1993 · PMID 8226809not yet assessed
-
Syndrome X: what's old, what's new, what's etiologic? ↗Journal of Clinical Investigation · 1993 · PMID 8325997not yet assessed
-
EFFECT OF LOVASTATIN ON VLDL METABOLISM IN SUBJECTS WITH COMBINED HYPERLIPIDEMIA; EVIDENCE FOR REDUCED ASSEMBLY AND SECRETION OF TRIGLYCERIDE RICH LIPOPROTEIN1993not yet assessed
-
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. ↗Journal of Clinical Investigation · 1992 · PMID 1430212not yet assessed
-
Hepatic Synthesis of Lipoproteins and Apolipoproteins ↗Seminars in Liver Disease · 1992 · PMID 1465621not yet assessed
-
Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells. ↗Journal of Biological Chemistry · 1992 · PMID 1429611not yet assessed
-
Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. ↗Journal of Biological Chemistry · 1991 · PMID 1848237not yet assessed
-
Lipoprotein Physiology in Nondiabetic and Diabetic States: Relationship to Atherogenesis ↗Diabetes Care · 1991 · PMID 1959476not yet assessed
-
Lipoprotein Physiology and Its Relationship to Atherogenesis ↗Endocrinology and Metabolism Clinics of North America · 1990 · PMID 2192871not yet assessed
-
Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. ↗Arteriosclerosis An Official Journal of the American Heart Association Inc · 1990 · PMID 2317159not yet assessed
-
High density lipoprotein cholesterol is reduced in patients with sarcoidosis ↗The American Journal of Medicine · 1989 · PMID 2929624not yet assessed
-
Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. ↗Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · PMID 2522296not yet assessed
-
The Effects of Diets on Plasma Lipids and Lipoprotein Phospholipids in Man1989not yet assessed
-
Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol ↗Metabolism · 1988 · PMID 3133537not yet assessed
-
Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. ↗PubMed · 1988 · PMID 3134523not yet assessed
-
Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis. ↗Journal of Clinical Investigation · 1987 · PMID 3680522not yet assessed
-
Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives ↗The American Journal of Medicine · 1987 · PMID 3318456not yet assessed
-
Very low density lipoprotein metabolism in diabetes mellitus ↗Diabetes/Metabolism Reviews · 1987 · PMID 3552533not yet assessed
-
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. ↗Journal of Clinical Investigation · 1986 · PMID 3095375not yet assessed
-
Hypocholesterolemia and acute myelogenous leukemia: Association between disease activity and plasma low-density lipoprotein cholesterol concentrations ↗Cancer · 1986 · PMID 3461875not yet assessed
-
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal ↗American Journal of Psychiatry · 1986 · PMID 3717447not yet assessed
-
Association of plasma lipoproteins with postheparin lipase activities. ↗Journal of Clinical Investigation · 1986 · PMID 3782469not yet assessed
-
Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia ↗Metabolism · 1986 · PMID 3747843not yet assessed
-
In vitro metabolism of apolipoprotein E ↗Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1986 · PMID 3778925not yet assessed
-
Kinetic analysis using specific radioactivity data ↗Methods in enzymology on CD-ROM/Methods in enzymology · 1986 · PMID 3523151not yet assessed
-
Clinical Syndrome and Lipid Metabolism in Hereditary Deficiency of Apolipoproteins A-I and C-III, Variant 1 ↗1986 · PMID 3099552not yet assessed
-
Medical complications of isotretinoin ↗Clinics in Dermatology · 1986 · PMID 2978683not yet assessed
-
Isolation of apolipoprotein E-containing lipoproteins by immunoaffinity chromatography ↗Methods in enzymology on CD-ROM/Methods in enzymology · 1986 · PMID 3724538not yet assessed
-
Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography ↗Methods in enzymology on CD-ROM/Methods in enzymology · 1986 · PMID 3523155not yet assessed
-
Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for Acne ↗New England Journal of Medicine · 1985 · PMID 2931603not yet assessed
-
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. ↗Journal of Clinical Investigation · 1985 · PMID 3973025not yet assessed
-
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. ↗Journal of Lipid Research · 1985 · PMID 4067427not yet assessed
-
Immunoaffinity isolation of apolipoprotein E-containing lipoproteins ↗Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1985 · PMID 3924105not yet assessed
-
Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: A saturable pathway distinct from the LDL receptor ↗Biochemical and Biophysical Research Communications · 1985 · PMID 3970709not yet assessed
-
Evaluation of 99mTc-LDL for studying lipoprotein metabolism and imaging atherosclerotic lesions in vivoJournal of Nuclear Medicine · 1985not yet assessed
-
Lipoprotein metabolism in cholesteryl ester storage disease evidence that apolipoprotein b production is regulated by endogenous cholesterol synthesis1985not yet assessed
-
Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease ↗Clinical Genetics · 1984 · PMID 6432380not yet assessed
-
Diet and the decrease of coronary heart disease ↗The American Journal of Cardiology · 1984 · PMID 6475764not yet assessed
-
Very low-density lipoprotein metabolism in an unusual case of lipoatrophic diabetes ↗Metabolism · 1984 · PMID 6381960not yet assessed
-
Hypocholesterolemia in myeloproliferative diseases with myelofibrosis. ↗PubMed · 1984 · PMID 6382303not yet assessed
-
Treatment of common lipoprotein disorders ↗Progress in Cardiovascular Diseases · 1984 · PMID 6330792not yet assessed
-
Protocol for efficient plasma sampling for low density lipoprotein turnover studies. ↗Journal of Lipid Research · 1984 · PMID 6530595not yet assessed
-
Combined Lipase Deficiency ( <i>cld</i> ): a Lethal Mutation on Chromosome 17 of the Mouse ↗Science · 1983 · PMID 6857276not yet assessed
-
Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemia ↗Cancer · 1983 · PMID 6572087not yet assessed
-
Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography. ↗Journal of Lipid Research · 1983 · PMID 6631249not yet assessed
-
Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases. ↗Arteriosclerosis An Official Journal of the American Heart Association Inc · 1983 · PMID 6847522not yet assessed
-
Case Report: Transient Lipoprotein Lipase Deficiency with Hyperchylomicronemia ↗The American Journal of the Medical Sciences · 1983 · PMID 6614044not yet assessed
-
Lipoprotein Metabolism during Acute Inhibition of Hepatic Triglyceride Lipase in the Cynomolgus Monkey ↗Journal of Clinical Investigation · 1982 · PMID 7174789not yet assessed
-
Metabolism of Cholesterol and Plasma Triglycerides in Nonketotic Diabetes Mellitus ↗Diabetes · 1982 · PMID 6759223not yet assessed
-
Increased Low-Density-Lipoprotein Catabolism in Myeloproliferative Disorders ↗Annals of Internal Medicine · 1982 · PMID 7059093not yet assessed
-
Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet. ↗Journal of Clinical Investigation · 1982 · PMID 6129260not yet assessed
-
Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: Effect of dietary restriction ↗Diabetologia · 1982 · PMID 6757031not yet assessed
-
Lipoproteins as risk factors for vascular disease in diabetes. ↗PubMed · 1982 · PMID 6981757not yet assessed
-
Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia effect of portacaval shunting ↗Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1982 · PMID 7126604not yet assessed
-
Compartmental Models for the Study of Apoprotein B Catabolism in Man ↗Elsevier eBooks · 1982not yet assessed
-
Characterization of hypocholesterolemia in myeloproliferative disease ↗The American Journal of Medicine · 1981 · PMID 7282748not yet assessed
-
Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. ↗Journal of Lipid Research · 1981 · PMID 7240960not yet assessed
-
Effect of a high carbohydrate diet on apoprotein-B catabolism in man ↗Metabolism · 1981 · PMID 7207206not yet assessed
-
Effect of Insulin Therapy on Insulin Resistance in Type II Diabetic Subjects: Evidence for Heterogeneity ↗Diabetes · 1981 · PMID 7021272not yet assessed
-
Lipoprotein metabolism in nonresponders to increased dietary cholesterol. ↗Arteriosclerosis An Official Journal of the American Heart Association Inc · 1981 · PMID 7347209not yet assessed
-
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins ↗American Journal of Physiology-Endocrinology and Metabolism · 1980 · PMID 7435612not yet assessed
-
The use of continuous insulin infusion for the peripartum management of pregnant diabetic women ↗American Journal of Obstetrics and Gynecology · 1978 · PMID 686085not yet assessed
-
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins. ↗Journal of Lipid Research · 1978 · PMID 209113not yet assessed
-
Investigation of insulin resistance during diabetic ketoacidosis: Role of counterregulatory substances and effect of insulin therapy ↗Metabolism · 1977 · PMID 408581not yet assessed
-
Induction of Hypertriglyceridemia by a Low-Fat Diet ↗The Journal of Clinical Endocrinology & Metabolism · 1976 · PMID 1262445not yet assessed
-
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. ↗Journal of Clinical Investigation · 1975 · PMID 1117064not yet assessed
-
Metabolic effects of increased caloric intake in man ↗Metabolism · 1975 · PMID 1117841not yet assessed
-
Further Evidence that Insulin Resistance Exists in Patients with Chemical Diabetes ↗Diabetes · 1974 · PMID 4852112not yet assessed
-
Moderate Ethanol Ingestion and Plasma Triglyceride Levels ↗Annals of Internal Medicine · 1974 · PMID 4359737not yet assessed
-
Hypercalcemia and Complete Heart Block ↗Annals of Internal Medicine · 1973 · PMID 4761917not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
No ORCID on record to anchor it (≈⅓ of researchers have none), so this rests on name disambiguation alone. See every “Ginsberg H” paper on PubMed ↗